High-Precision Assistance For Eye Surgery

    Preceyes develops innovative robotic solutions to assist eye surgeons in performing the most demanding surgical tasks. Preceyes enables the development of new, high-precision treatments and facilitates existing vitreoretinal surgery.

    Precision

    Scaling of movements and filtering of hand tremors yield unprecedented steadiness and precision, whilst standby functionality improves control and enables to relax during surgery by freezing the instrument position.

    Safety

    Whilst the hybrid setup allows the surgeon to maintain patient contact, the instrument minimizes residual eye movements by holding the cannula and safety boundaries are employed to limit instrument movements.

    Workflow Optimization

    During surgery, the instrument is easily included to assist in a specific task and instruments are easily changed, whilst instrument movements are recorded for post-surgical evaluation and training purposes.

    Benefits

    Existing surgery

    Eye surgeons work at their limits. To ensure safe surgery, many years of training and the highest level of motor skills are demanded. Worldwide, over 6.5 million people with vitreoretinal diseases are treated annually, 20% of which includes highly-delicate surgical procedures. The PRECEYES Surgical System facilitates these treatments by assisting eye surgeons in performing the most demanding surgical tasks.

    New surgery

    Worldwide, an estimated 50 to 75 million people suffer from visual impairment related to retinal diseases that have no adequate treatment yet; the leading cause of vision loss in industrialized countries. High-precision delivery of innovative drugs, gene therapy and cell products are widely anticipated to enable adequate treatments in the near future. Preceyes delivers the high level of precision that is demanded for these treatments.

    Company

    Strategically located in the Dutch Brainport region, the high-precision capital of the world, Preceyes builds upon excellent research of Eindhoven University of Technology. Incorporated in 2011, Preceyes has developed the PRECEYES Surgical System, which has successfully been validated in in-vivo preclinical investigations. The first in-human clinical investigation is anticipated for 2016, targeting CE approval and market introduction in 2018.

    Team

    Preceyes brings micro precision to micro surgery

    Recent articles